Tumala, Cherlinda A.

HRN: 28-68-39  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/11/2026
CEFTRIAXONE 1G (VIAL)
03/11/2026
03/17/2026
IV DRIP
2
OD
UTI
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Urinary Tract    Compliance to guidelines: